Skip to content

Bilateral Electroacupuncture Based on Interhemispheric Inhibition Principle for Post-Stroke Dysphagia: A Randomized Controlled Trial

Bilateral Electroacupuncture Based on Interhemispheric Inhibition Principle for Post-Stroke Dysphagia: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002018
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Dysphagia

Interventions

Neuromuscular electrical stimulation Group:Basic drug therapy, rehabilitation therapy, neuromuscular electrical stimulation
Non-Electroacupuncture Group:Basic drug therapy, rehabilitation therapy, bilateral acupuncture
Electroacupuncture group Group:Basic drug therapy, rehabilitation therapy, bilateral electroacupuncture

Sponsors

Xiamen Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meeting the diagnostic criteria for stroke in both Chinese and Western medicine. 2) First-onset stroke, with disease duration between 2 weeks and 1 year. 3) Meeting the above diagnostic criteria for dysphagia, with imaging evidence indicating unilateral supratentorial infarction or hemorrhage. 4) Clinically stable and able to cooperate in completing the relevant examinations. 5) Aged between 35 and 80 years, regardless of sex. 6) Able to cooperate in completing acupuncture and related treatments; the patient and their family voluntarily agree to participate in this study and have signed the informed consent form. 7) Not participating in any other clinical trial.

Exclusion criteria

Exclusion criteria: 1) Patients with large unilateral corpus callosum lesions caused by cerebral infarction or cerebral hemorrhage. 2) Those with concomitant disturbances of consciousness or psychiatric disorders; or with a history of epileptic seizures or current epilepsy; or those who are emotionally agitated, exhibit restlessness or aggressive behaviors, and are unable to cooperate with acupuncture treatment. 3) Patients with acute infectious diseases, severe diabetes, organic lesions of the cardiovascular, hepatic, or renal systems, hematological or endocrine disorders, or malignancies; or those with unstable vital signs. 4) Dysphagia resulting from other causes, such as oral or head–neck tumors, musculoskeletal diseases, Parkinson's disease, refusal to eat due to unconsciousness, or dietary aversion. 5) Those allergic to contrast agents, swallowing therapy device electrodes, or conductive paste. 6) Patients with skin ulceration, infection, or dermatitis at the acupuncture sites. 7) Pregnant or lactating women. 8) Patients with cranial defects or intracranial metallic implants that may interfere with electroencephalographic signal acquisition.

Design outcomes

Primary

MeasureTime frame
the Rosenbek Penetration-Aspiration Scale (PAS) score via Videofluoroscopic Swallow Study (VFSS);

Secondary

MeasureTime frame
electroencephalography (EEG);

Countries

The People's Republic of China

Contacts

Public ContactYanxun Huang

Xiamen Hospital of Traditional Chinese Medicine

fumihiko_mki3@163.com13850047418

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026